Outlook Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Syntone Ventures LLC(11.4%),Syntone LLC(11.4%)等
Outlook Therapeutics | 4:持股变动声明-股东 Syntone Ventures LLC
Outlook Therapeutics | D:发行公告
Outlook Therapeutics | SC 13G:超过5%持股股东披露文件-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%)等
Outlook Therapeutics | D:发行公告
Outlook Therapeutics | 4:持股变动声明-董事 Haddadin Yezan Munther
Outlook Therapeutics | SC 13G:超过5%持股股东披露文件-Velan Capital Master Fund LP(5.6%),Velan Capital Holdings LLC(5.6%)等
Outlook Therapeutics | SC 13G:超过5%持股股东披露文件-Tang Capital Partners, LP(9.99%),Tang Capital Management, LLC(9.99%)等
Outlook Therapeutics | 4:持股变动声明-高管 KENYON LAWRENCE A
Outlook Therapeutics | 4:持股变动声明-高管 Evanson Jeff
Outlook Therapeutics | 4:持股变动声明-高管 TRENARY C RUSSELL III
Outlook Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-GMS Ventures and Investments(37.0%),Ghiath M. Sukhtian(37.0%)
Outlook Therapeutics | 4:持股变动声明-董事 Sukhtian Ghiath M.
Outlook Therapeutics | 4:持股变动声明-高管 Evanson Jeff
Outlook Therapeutics | 4:持股变动声明-董事 Haller Julia A
Outlook Therapeutics | 4:持股变动声明-董事 Huang Andong
Outlook Therapeutics | 4:持股变动声明-董事 Auffarth Gerd
Outlook Therapeutics | 4:持股变动声明-董事 Gangolli Julian S
Outlook Therapeutics | 4:持股变动声明-董事 Haddadin Yezan Munther
Outlook Therapeutics | 4:持股变动声明-董事 HILZINGER KURT J
暂无数据